Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: A unified diagnostic approach

Journal of Clinical Pathology

Volumn 51, Issue 8, 1998, Pages 606-610

  Surentheran, Thirunavukarasu ^a   Harwood, Catherine A ^a   Spink, Patricia J ^a   Sinclair, Anne L ^a   Leigh, Irene M ^a   Proby, Charlotte M ^a   McGregor, Jane M ^a   Breuer, Judith ^a,b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Degenerate PCR; Human papillomavirus; Viral carcinogenesis

Indexed keywords

VIRUS DNA;

ANUS CANCER; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMODYSPLASIA VERRUCIFORMIS; GENITAL TRACT CANCER; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

EID: 0031825101     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.8.606     Document Type: Article

References (23)

1. Shamanin V, Glover M, Rausch C, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994;54:4610-13.
2. Berkhout RJM, Tieben LM, Smits HL, et al. Detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
3. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and non-immunosuppressed patients. J Natl Cancer Inst 1996;88:802-11.
4. de Jong-Tieben LM, Berkhout RJM, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from transplant recipients. J Invest Dermatol 1995;105:367-71.
5. de Villiers E-M. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994; 186:1-12.
6. Chan SY, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. J Virol 1995;69:3074-83.
7. Vousden KH. Human papillomaviruses and cervical carcinoma. Cancer Cells 1989;1:43-50.
8. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
9. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. In: Ciba Foundation Symposium 120. London: Ciba Foundation, 1986:157-74.
10. Majewski S, Jahlonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995;131:1312-18.
11. Tieben LM, Berkhout RJ, Smits HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994;131:226-30.
12. van den Brule AJC, Snijders PJF, Meijer CJLM, et al. PCR-based detection of genital HPV genotypes: an update and future perspectives. Papillomavirus Report 1993;4:95-9.
13. Proby C, Storey A, McGregor J, et al. Does human papillomavirus infection play a role in non-melanoma skin cancer? Papillomavirus Report 1996;7:53-60.
14. McGregor JM, Proby CM. The role of papillomaviruses in human non-melanoma skin cancer. In: Leigh IM, Newton Bishop JA, Kripke ML, eds. Cancer surveys, vol 26: skin cancer. New York: Cold Spring Harbour Laboratory Press, 1996:219-36.
15. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. New York: Cold spring Harbour Press, 1982.
16. Shamanin V, Delius H, de Villiers E-M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994;75:1149-56.
17. Manos MM, Ting Y, Wright DK, et al. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14.
18. Smith SE, Davis IC, Leshin B, et al. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients. Arch Dermatol 1993;129:1585-8.
19. McGregor JM, Farthing A, Crook T, et al. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol 1994;30:701-6.
20. Saiki RK, Scharf S, Faloona F. Enzymatic amplification of β-globin genomic sequence and restriction site analysis for diagnosis of sickle cell anaemia. Science 1985;230:1350-4.
21. Dyall-Smith D, Trowell H, Dyall-Smith MA. Benign human papillomavirus infection in renal transplant recipients. Int J Dermatol 1991;30:785-9.
22. Gassenmaier A, Fuchs P, Scell H, et al. Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch Derm Res 1986;278:219-23.
23. International Agency for Research on Cancer. Human papillomaviruses. (Monographs on the evaluation of the carcinogenic risk to humans, vol 64.) Lyons: IARC, 1995:196-212.